Rizatriptan
Last Updated: 06/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 497 publications
Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model.
Journal: International journal of pharmaceutics
Published: December 12, 2025
Serotonin Syndrome With Quetiapine, Rizatriptan, Gabapentin, and Propranolol.
Journal: The primary care companion for CNS disorders
Published: December 10, 2025
Measurement and modeling of rizatriptan in supercritical CO2 for pharmaceutical processing.
Journal: Scientific reports
Published: September 05, 2025
A comparison of the persistence of acute treatment with rimegepant versus oral triptans in patients with migraine: A retrospective analysis of US claims data.
Journal: Cephalalgia : an international journal of headache
Published: July 28, 2025
A Pharmacovigilance Study from 2004 to 2024 Utilizing the FDA Adverse Event Reporting System (FAERS) Examines Ischemic Adverse Events Linked to Triptan Use in Migraine Therapy.
Journal: Journal of pain research
Published: July 04, 2025
Meloxicam and Rizatriptan Benzoate.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: June 25, 2025
Rizatriptan vs Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: May 12, 2025
Neuroinflammatory crosstalk in migraine: consolidated activity of rizatriptan and meloxicam in suppressing CGRP-induced nociception and COX-mediated inflammation.
Journal: Inflammopharmacology
Published: May 07, 2025
A fixed-dose combination of meloxicam and rizatriptan (Symbravo) for migraine.
Journal: The Medical letter on drugs and therapeutics
Published: April 22, 2025
Induction of more severe central sensitization in a medication overuse headache model mice through active ingestion of rizatriptan.
Journal: The journal of headache and pain
Published: March 13, 2025
Evaluating Triptan Safety in Pediatric Migraine Management: A Comprehensive Pharmacovigilance Analysis.
Journal: Journal of pain research
Published: March 06, 2025
Pediatric Triptan-induced Reversible Cerebral Vasoconstriction Syndrome with Both Hemorrhagic and Ischemic Stroke: Case Report and Literature Review.
Journal: NMC case report journal
Published: February 06, 2025
Last Updated: 06/24/2026